529 related articles for article (PubMed ID: 17556661)
1. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
Santiago FS; Ishii H; Shafi S; Khurana R; Kanellakis P; Bhindi R; Ramirez MJ; Bobik A; Martin JF; Chesterman CN; Zachary IC; Khachigian LM
Circ Res; 2007 Jul; 101(2):146-55. PubMed ID: 17556661
[TBL] [Abstract][Full Text] [Related]
2. The balance of power: the law of Yin and Yang in smooth muscle cell fate. Is YY1 a vascular protector?
Aikawa M
Circ Res; 2007 Jul; 101(2):111-3. PubMed ID: 17641231
[No Abstract] [Full Text] [Related]
3. Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1.
Ishii H; Hulett MD; Li JM; Santiago FS; Parish CR; Khachigian LM
Int J Oncol; 2012 May; 40(5):1575-80. PubMed ID: 22322893
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.
Kavurma MM; Khachigian LM
J Cell Biochem; 2004 Nov; 93(5):904-16. PubMed ID: 15389873
[TBL] [Abstract][Full Text] [Related]
5. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Kavurma MM; Khachigian LM
J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
7. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
8. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
10. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.
Zhang W; Kornblau SM; Kobayashi T; Gambel A; Claxton D; Deisseroth AB
Clin Cancer Res; 1995 Sep; 1(9):1051-7. PubMed ID: 9816079
[TBL] [Abstract][Full Text] [Related]
11. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
[TBL] [Abstract][Full Text] [Related]
12. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
14. Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.
Zurlo D; Leone C; Assante G; Salzano S; Renzone G; Scaloni A; Foresta C; Colantuoni V; Lupo A
Mol Carcinog; 2013 Jan; 52(1):1-17. PubMed ID: 22025467
[TBL] [Abstract][Full Text] [Related]
15. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
Weiss RH; Randour CJ
Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
[TBL] [Abstract][Full Text] [Related]
18. Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.
Liu PY; Hsieh TY; Liu ST; Chang YL; Lin WS; Wang WM; Huang SM
Exp Cell Res; 2011 Dec; 317(20):2925-37. PubMed ID: 22001409
[TBL] [Abstract][Full Text] [Related]
19. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
20. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
